Skip to main content
SpringerLink
Log in

Can the Fatal Toxicity of Antidepressant Drugs be Predicted with Pharmacological and Toxicological Data?

  • Original Research Article
  • Published:
Drug Safety Aims and scope Submit manuscript

Summary

Antidepressant drugs are among the most common drugs involved in fatal poisoning and large variations between antidepressant drugs have been noted. Despite the fact that a large number of studies have calculated a fatal toxicity index (FTI) for antidepressants, no serious attempts have been made to compare the differences in fatal toxicity against known pharmacological and toxicological differences in receptor affinity. It is potentially from such data that screening of drugs during their preclinical development can be facilitated.

We examined correlations between the FTI and noradrenaline (norepinephine)/serotonin (5-hydroxytryptamine; 5-HT) reuptake inhibition selectivity, the dose that is lethal to 50% of animals (LD50), lipid solubility, and antagonist activity at cholinergic, histaminergic, α-adrenergic and γ-aminobutyric acid (GABA)A receptors or sodium and potassium channel blocking effects. We obtained data on the number of fatal poisonings between 1983 and 1992 in England and Wales caused by a single antidepressant drug from the Department of Health in the UK. This number was divided by the number of prescriptions in England for these drugs over this time to derive a FTI of deaths per million prescriptions.

The highest FTIs were for amoxapine, viloxazine, desipramine and doth-iepin. Lofepramine, paroxetine and fluoxetine had very low FTIs. Using Poisson regression, there was a significant positive relationship between the FTI of antidepressant drugs and their lethal toxicity in animals, and measures of their cardiac effects. The relative noradrenaline/serotonin reuptake inhibition, lipid solubility and their potency at histamine H1, muscarinic and α1-adrenergic receptors had no substantial association with the FTI. Limited data suggest that some cardiac effects and potency as a GABAA antagonist may be important predictors of significant toxicity. Further data using standardised bio-assays are needed to compare the direct cardiac effects of antidepressants. Thus, the best current preclinical indicator of fatal toxicity in humans is the LD50 in animal studies. Clearly, there are humane and practical reasons for developing a better preclinical indicator of toxicity in overdose for this rapidly expanding group of drugs.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Log in via an institution

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Institutional subscriptions

Similar content being viewed by others

References

  1. Crome P. The toxicity of drugs used for suicide. Acta Psychiatr Scand 1993: Suppl. 371: 33–7

    Article  CAS  Google Scholar 

  2. King LA, Moffat AC. A possible index of fatal drug toxicity in humans. Med Sci Law 1983: 23: 193–8

    PubMed  CAS  Google Scholar 

  3. Cassidy S, Henry J. Fatal toxicity of antidepressant drugs in overdose. BMJ 1987: 295: 1021–4

    Article  PubMed  CAS  Google Scholar 

  4. Montgomery SA, Pinder RM. Do some antidepressants promote suicide? Psychopharmacology 1987: 92: 265–6

    Article  PubMed  CAS  Google Scholar 

  5. Henry JA, Antao CA. Suicide and fatal antidepressant poisoning. Eur J Med 1992: 1: 343–8

    PubMed  CAS  Google Scholar 

  6. Henry JA, Alexander CA, Sener EK. Relative mortality from overdose of antidepressants. BMJ 1995: 310: 221–4

    Article  PubMed  CAS  Google Scholar 

  7. Kapur S, Mieczkowski T, Mann J. Antidepressant medications and the relative risk of suicide attempt and suicide. JAMA 1992: 268(24): 3441–5

    Article  PubMed  CAS  Google Scholar 

  8. Kelleher MJ, Daly M, Kelleher MJA. The influence of antidepressants in overdose on the increased suicide rate in Ireland between 1971 and 1988. Br J Psychiatry 1992: 161: 625–8

    Article  PubMed  CAS  Google Scholar 

  9. Henry JA, Cassidy SL. Acute non-specific toxicity. In: Ballantyne B, Marrs T, Turner P, editors. General and applied toxicology I. Basingstoke, UK: MacMillan Press, 1993

    Google Scholar 

  10. Geigy Scientific Tables Volume 2. Introduction to statistics. Statistical tables. In: Lentner C, editor. Mathematical formulae. 8th ed. Basle, Switzerland: Ciba-Geigy Ltd, 1984

  11. Pharmaceutical Index. Intercontinental Medical Statistics, UK 1983-92

  12. World Health Organization. Anatomical therapeutic chemical (ATC) classification index including defined daily dose (DDDs) for plain substances. Oslo: WHO Collaborating Centre for Drug Statistics Methodology, 1994

  13. Richelson E, Pfenning M. Blockade by antidepressants and related compounds of biogenic amine uptake into rat brain syn-aptosomes: most antidepressants selectively block norepinephrine uptake. Eur J Pharmacol 1984: 104: 277–86

    Article  PubMed  CAS  Google Scholar 

  14. Richelson E. The pharmacology of antidepressants at the synapse: Focus on newer compounds. J Clin Psychiatry 1994: 55 Suppl. A: 34–9

    PubMed  Google Scholar 

  15. Richelson E, Nelson A. Antagonism by antidepressants of neurotransmitter receptors of normal human brain in vitro. J Pharmacol Exp Ther 1984: 230: 94–102

    PubMed  CAS  Google Scholar 

  16. Lancaster SG, Gonzalez JP. Lofepramine: a review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in depressive illness. Drugs 1989: 37(2): 123–40

    Article  PubMed  CAS  Google Scholar 

  17. Squires RF, Saederup E. Mono N-aryl ethylenediamine and pi-perazine derivatives are GABAA receptor blockers: implications for psychiatry. Neurochem Res 1993: 18(7): 787–93

    Article  PubMed  CAS  Google Scholar 

  18. Squires RF, Saederup E. Antidepressants and metabolites that block GABAA receptors coupled to 35S-t-butylbicyclo-phosphorothionate binding sites in rat brain. Brain Res 1988: 441(1–2): 15–22

    Article  PubMed  CAS  Google Scholar 

  19. Cain CR, Hamilton TC, Norton J, et al. Relative lack of car-diotoxicity of paroxetine in animal models. Acta Psychiatr Scand 1989: 80 Suppl. 350: 27–30

    Article  Google Scholar 

  20. Arita M, Wada A, Takara H, et al. Inhibition of 22Na influx by tricyclic and tetracyclic antidepressants and binding of [3H] Imipramine in bovine adrenal medullary cells. J Pharmacol Exp Ther 1987: 243: 342–8

    PubMed  CAS  Google Scholar 

  21. Perez-Vizcaino F, Carron R, Delpon E, et al. Effects of (S)-nafenodone, a new antidepressant, in isolated guinea-pig atrial and ventricular muscle fibres. Eur J Pharmacol 1991: 199: 43–50

    Article  PubMed  CAS  Google Scholar 

  22. Dollery CT, editor. Therapeutic drugs. Edinburgh: Churchill Livingstone, 1991

    Google Scholar 

  23. Feray JC, Garay R. Demonstration of a Na+: Mg2+ exchange in human red cells by its sensitivity to tricyclic antidepressant drugs. Naunyn Schmiedebergs Arch Pharmacol 1988: 338(3): 332–7

    Article  PubMed  CAS  Google Scholar 

  24. Budavari S, O’Neil MJ, Smith A, et al., editors. The Merck index: an encyclopaedia of chemicals, drugs and biologicals. 12th ed. Rahway, NJ: Merck & Co, 1996

    Google Scholar 

  25. Moffat AC, editor. Clarkes isolation and identification of drugs. 2nd ed. London: The Pharmaceutical Press, 1986

    Google Scholar 

  26. Henry JA. Epidemiology and relative toxicity of antidepressant drugs in overdose. Drug Saf 1997: 16(6): 374–90

    Article  PubMed  CAS  Google Scholar 

  27. Dwyer PS, Jones IF. Fatal self-poisoning in the UK and the paracetamol/dextropropoxyphene combination. Hum Toxicol 1984: 3: 145S–74S

    Article  PubMed  Google Scholar 

  28. Isaacson G, Redfors I, Wasserman D, et al. Choice of antidepressants: questionnaire survey of psychiatrists and general practitioners in two areas of Sweden. BMJ 1994: 309: 1546–9

    Article  Google Scholar 

  29. Brasch H. Activators of sodium, calcium and potassium channels modulate the cardiac effects of quinidine in vitro. Pharmacol Toxicol 1995: 77: 346–51

    Article  PubMed  CAS  Google Scholar 

  30. Taboulet P, Michard F, Muszynski J, et al. Cardiovascular repercussions of seizures during cyclic antidepressant poisoning. J Toxicol Clin Toxicol 1993: 31: 531–51

    Article  PubMed  CAS  Google Scholar 

  31. Wedin GP, Oderda G, Klein-Schwartz W, et al. Relative toxicity of cyclic antidepressants. Ann Emerg Med 1986: 14: 797–804

    Article  Google Scholar 

  32. Buckley NA, Dawson AH, Whyte IM, et al. Greater toxicity in overdose of dothiepin than other tricyclic antidepressants. Lancet 1994: 343: 159–62

    Article  PubMed  CAS  Google Scholar 

  33. Buckley NA, McManus P. Fatal toxicity of drugs used in the treatment of psychotic illness. Br J Psychiatry 1998. In press

  34. Roose SP, Glassman AH. Antidepressant choice in the patient with cardiac disease. Lessons from the Cardiac Arrhythmia Suppression Trial (CAST) studies. J Clin Psychiatry 1994: 55 Suppl. A: 83–7

    PubMed  Google Scholar 

  35. Anderson IM, Tomenson BM. Treatment discontinuation with selective serotonin reuptake inhibitors compared with tricyclic antidepressants: a meta-analysis. BMJ 1995: 310: 1433–8

    Article  PubMed  CAS  Google Scholar 

  36. Owen A. Nearly a third of deaths related to poisoning [letter]. BMJ 1994: 308: 915

    Article  PubMed  CAS  Google Scholar 

  37. Jick SS, Dean AD, Jick H. Antidepressants and suicide. BMJ 1995: 310: 215–8

    Article  PubMed  CAS  Google Scholar 

  38. Nordentoft M, Breum L, Munck LK, et al. High mortality by natural and unnatural causes: a 10 year follow up study of patients admitted to a poisoning treatment centre after suicide attempts. BMJ 1993: 306: 1637–41

    Article  PubMed  CAS  Google Scholar 

Download references

Author information

Authors and Affiliations

  1. The National Centre for Epidemiology & Population Health, Australian National University, Canberra, Australian Capital Territory, 0200, Australia

    Nicholas A. Buckley

  2. Department of Health and Family Services, Drug Utilisation Sub-Committee, Canberra, Australian Capital Territory, Australia

    Peter R. McManus

Authors
  1. Nicholas A. Buckley
    View author publications

    You can also search for this author in PubMed Google Scholar

  2. Peter R. McManus
    View author publications

    You can also search for this author in PubMed Google Scholar

Rights and permissions

Reprints and permissions

About this article

Cite this article

Buckley, N.A., McManus, P.R. Can the Fatal Toxicity of Antidepressant Drugs be Predicted with Pharmacological and Toxicological Data?. Drug-Safety 18, 369–381 (1998). https://doi.org/10.2165/00002018-199818050-00006

Download citation

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.2165/00002018-199818050-00006

Keywords

Search

Navigation